OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety Assessment and Dose Selection for First-in-Human Clinical Trials With Immunomodulatory Monoclonal Antibodies

HTML

Year: 2009
Type: article
Source: Clinical Pharmacology & Therapeutics
DOI: 10.1038/clpt.2008.273
Authors: PY Muller, FR Brennan
Institutions: Novartis (Switzerland), Novartis Institutes for BioMedical Research
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: dose selection, safety assessment, non-human primates, species selection, microdosing, immunogenicity, cytokine release syndrome, autoimmunity, immunosuppression, therapeutic formulation, regulatory requirements, TGN1412
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1981952228
FWCI: 5.176
Cites: 39
Cited by: 112
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security